Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor.
Hyunkyung ParkHyeong-Joon KimSang-Kyun SohnYoonsuk BaikDongho KimSung-Yeoun LeeJee Hyun KongHawk KimDong-Yeop ShinJae-Sook AhnJinny ParkSeonyang ParkInho KimPublished in: Therapeutic advances in hematology (2023)
transcript levels on ddPCR should be taken into consideration when deciding whether to discontinue TKI therapy.